← Back to directory

Andrew D. Krystal

Researcher Next ID · RN-026340

Researcher · Psychology

University of California, San Francisco

San Francisco, Argentina

Not currently recruitingFunding unknown
Works count
467
Citation count
26,452
H-index
81
i10-index
225

Research interests

Psychology
Neuroscience
Medicine
Sleep and related disorders
Sleep and Wakefulness Research
Circadian rhythm and melatonin
Electroconvulsive Therapy Studies
Treatment of Major Depression

Publications

  • International Consensus Statement on Obstructive Sleep Apnea

    International Forum of Allergy & Rhinology · 2022 · https://doi.org/10.1002/alr.23079

  • A Delphi-method-based consensus guideline for definition of treatment-resistant depression for clinical trials

    Molecular Psychiatry · 2021 · https://doi.org/10.1038/s41380-021-01381-x

  • Closed-loop neuromodulation in an individual with treatment-resistant depression

    Nature Medicine · 2021 · https://doi.org/10.1038/s41591-021-01480-w

  • State-dependent responses to intracranial brain stimulation in a patient with depression

    Nature Medicine · 2021 · 10.1038/s41591-020-01175-8

  • A randomized proof-of-mechanism trial applying the ‘fast-fail’ approach to evaluating κ-opioid antagonism as a treatment for anhedonia

    Nature Medicine · 2020 · 10.1038/s41591-020-0806-7

  • The assessment and management of insomnia: an update

    World Psychiatry · 2019 · 10.1002/wps.20674

  • British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders: An update

    Journal of Psychopharmacology · 2019 · 10.1177/0269881119855343

  • Cognitive Behavioral Insomnia Therapy for Those With Insomnia and Depression: A Randomized Controlled Clinical Trial

    SLEEP · 2017 · 10.1093/sleep/zsx019

  • International randomized-controlled trial of transcranial Direct Current Stimulation in depression

    Brain stimulation · 2017 · 10.1016/j.brs.2017.10.011

  • Consensus Recommendations for the Clinical Application of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Depression

    The Journal of Clinical Psychiatry · 2017 · 10.4088/jcp.16cs10905

  • Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline

    Journal of Clinical Sleep Medicine · 2017 · https://doi.org/10.5664/jcsm.6470

  • National Sleep Foundation's sleep quality recommendations: first report

    Sleep Health · 2016 · https://doi.org/10.1016/j.sleh.2016.11.006

  • Insomnia disorder

    Nature Reviews Disease Primers · 2015 · 10.1038/nrdp.2015.26

  • Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trial

    The Lancet Neurology · 2014 · 10.1016/s1474-4422(14)70053-5

  • Suvorexant in Patients With Insomnia: Results From Two 3-Month Randomized Controlled Clinical Trials

    Biological Psychiatry · 2014 · 10.1016/j.biopsych.2014.10.003

  • Psychiatric Disorders and Sleep

    Neurologic Clinics · 2012 · 10.1016/j.ncl.2012.08.018

  • The Consensus Sleep Diary: Standardizing Prospective Sleep Self-Monitoring

    SLEEP · 2012 · https://doi.org/10.5665/sleep.1642

  • Daily Left Prefrontal Repetitive Transcranial Magnetic Stimulation in the Acute Treatment of Major Depression: Clinical Predictors of Outcome in a Multisite, Randomized Controlled Clinical Trial

    Neuropsychopharmacology · 2008 · 10.1038/npp.2008.118

  • Measuring sleep quality

    Sleep Medicine · 2008 · 10.1016/s1389-9457(08)70011-x

  • A Comparison of Rates of Residual Insomnia Symptoms Following Pharmacotherapy or Cognitive-Behavioral Therapy for Major Depressive Disorder

    The Journal of Clinical Psychiatry · 2007 · 10.4088/jcp.v68n0211

  • Nightly Treatment of Primary Insomnia With Eszopiclone for Six Months: Effect on Sleep, Quality of Life, and Work Limitations

    SLEEP · 2007 · 10.1093/sleep/30.8.959

  • Eszopiclone Co-Administered With Fluoxetine in Patients With Insomnia Coexisting With Major Depressive Disorder

    Biological Psychiatry · 2006 · 10.1016/j.biopsych.2006.01.016

  • Behavioral Insomnia Therapy for Fibromyalgia Patients

    Archives of Internal Medicine · 2005 · 10.1001/archinte.165.21.2527

  • An evaluation of the efficacy and safety of eszopiclone over 12 months in patients with chronic primary insomnia

    Sleep Medicine · 2005 · 10.1016/j.sleep.2005.06.004

  • Sustained Efficacy of Eszopiclone Over 6 Months of Nightly Treatment: Results of a Randomized, Double-Blind, Placebo-Controlled Study in Adults with Chronic Insomnia

    SLEEP · 2003 · 10.1093/sleep/26.7.793

  • NREM Sleep EEG Frequency Spectral Correlates of Sleep Complaints in Primary Insomnia Subtypes

    SLEEP · 2002 · 10.1093/sleep/25.6.626

Current projects

    No projects listed.